Singapore Stock Exchange - Equity Investments

Wednesday, October 26, 2022

Manulife US Reit - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
06/30/21	Phillip	Manulife US Reit	0.795	0.84	Buy
08/13/21	DBS Vickers	Manulife US Reit	0.765	0.88	Buy	DCF
08/13/21	Kim Eng	Manulife US Reit	0.765	1	Buy	DDM
08/13/21	UOB Kay Hian	Manulife US Reit	0.765	0.84	Buy	DDM
08/25/21	Phillip	Manulife US Reit	0.73	0.84	Accumulate
09/07/21	Amfrasers	Manulife US Reit	0.73	0.82	Outperform	DDM, Cut from $0.86
09/07/21	DMG & Partners	Manulife US Reit	0.73	0.9	Buy
11/05/21	CIMB	Manulife US Reit	0.695	0.918	Add	DDM
11/05/21	Kim Eng	Manulife US Reit	0.695	1	Buy	DDM
11/05/21	Phillip	Manulife US Reit	0.695	0.84	Accumulate	DDM
11/08/21	OCBC	Manulife US Reit	0.72	0.83	Buy
11/10/21	UOB Kay Hian	Manulife US Reit	0.71	0.84	Buy	DDM
12/01/21	CIMB	Manulife US Reit	0.71	0.918	Add	DDM
12/03/21	UOB Kay Hian	Manulife US Reit	0.685	0.87	Buy	DDM
12/06/21	Phillip	Manulife US Reit	0.695	0.84	Accumulate	DDM
12/15/21	DMG & Partners	Manulife US Reit	0.66	0.9	Buy
02/09/22	Lim & Tan	Manulife US Reit	0.645	0.87	Accumulate on weakness
02/10/22	CIMB	Manulife US Reit	0.63	0.89	Add
02/10/22	DBS Vickers	Manulife US Reit	0.63	0.88	Buy
02/10/22	DMG & Partners	Manulife US Reit	0.63	0.86	Buy
02/10/22	Kim Eng	Manulife US Reit	0.63	0.95	Buy
02/11/22	OCBC	Manulife US Reit	0.65	0.8	Buy
02/17/22	Phillip	Manulife US Reit	0.665	0.86	Buy	DDM
03/15/22	UOB Kay Hian	Manulife US Reit	0.63	0.8	Buy	DDM
05/10/22	UOB Kay Hian	Manulife US Reit	0.6	0.8	Buy	DDM
05/10/22	DBS Vickers	Manulife US Reit	0.6	0.88	Buy
05/10/22	Kim Eng	Manulife US Reit	0.6	0.9	Buy	DDM
05/10/22	DMG & Partners	Manulife US Reit	0.6	0.83	Buy	DDM
05/10/22	CIMB	Manulife US Reit	0.6	0.86	Add
05/11/22	OCBC	Manulife US Reit	0.6	0.77	Buy
05/26/22	DBS Vickers	Manulife US Reit	0.59	0.7	Buy	DCF
05/26/22	Kim Eng	Manulife US Reit	0.59	0.88	Buy
08/05/22	DBS Vickers	Manulife US Reit	0.595	0.7	Buy
08/05/22	CIMB	Manulife US Reit	0.595	0.78	Buy	DDM
08/05/22	DMG & Partners	Manulife US Reit	0.595	0.78	Buy	DDM
08/05/22	Kim Eng	Manulife US Reit	0.595	0.85	Buy
08/08/22	UOB Kay Hian	Manulife US Reit	0.59	0.74	Buy	DDM
09/15/22	Lim & Tan	Manulife US Reit	0.505	0.77	Accumulate
10/14/22	UOB Kay Hian	Manulife US Reit	0.39	0.63	Buy

Stock calls for 25 october 2022

Date	Analyst	Company	Last	Target	Call	Valuation
10/25/22	Credit Suisse	ART	0.875	0.97	Buy
10/25/22	DBS Vickers	Capitaland Integrated Commercial Trust	1.74	2.2	Buy
10/25/22	OCBC	Capitaland Integrated Commercial Trust	1.74	2.15	Buy
10/25/22	DMG & Partners	Capitaland Integrated Commercial Trust	1.74	2	Buy	DDM
10/25/22	Credit Suisse	Capitaland Integrated Commercial Trust	1.74	2.31	Buy
10/25/22	Citi Research	Capitaland Integrated Commercial Trust	1.74	2.35	Buy
10/25/22	UOB Kay Hian	DBS	32.39	45.75	Buy	GGM, PB1.94x FY23
10/25/22	Lim & Tan	DBS	32.39	39.5	Accumulate
10/25/22	DBS Vickers	IHH Healthcare	1.79	2.37	Buy	Ringgit $7.90 target price
10/25/22	Credit Suisse	Mapletree Commercial	1.55	2.05	Buy
10/25/22	DBS Vickers	OCBC	11.53	16.82	Buy	GGM, PB1.34x FY23
10/25/22	CIMB	Raffles Medical	1.21	1.6	Add

Sunday, October 23, 2022

Is co-exist policy or zero covid policy better? The truth is out!

We tabulated a metric table based on available statistics and the results confirmed that China was right to implement a zero covid policy.

	Co-Exist Policy (US)	Zero Covid Policy (China)	Winner
Infection (Million):	96.9	1.02	Zero Covid Policy (China)
Total death (‘000):	1006	5.2	Zero Covid Policy (China)
7-day ave case:	35287	982	Zero Covid Policy (China)
7-day ave death:	377	No death after May 2022	Zero Covid Policy (China)
Long covid case (Million):	24	Negligible	Zero Covid Policy (China)
Incapacitated 80% (Million):	19.2	Negligible	Zero Covid Policy (China)
Long covid unemployment: (Million), Brookings Institution	4	Negligible	Zero Covid Policy (China)
Long covid wage loss (Billion): Brookings Institution	170	Negligible	Zero Covid Policy (China)
GDP Q1:	-1.60%	4.80%	Zero Covid Policy (China)
GDP Q2:	-0.60%	0.40%	Zero Covid Policy (China)